Cargando…
Pomalidomide-induced hypothyroidism
Hypothyroidism is a recognized side effect of thalidomide drugs. We herein report a case of 83-year-old Irish female with a diagnosis of multiple myeloma and a background history of type 2 diabetes mellitus and hypertension. Our patient received pomalidomide and multiple courses of chemotherapy and...
Autores principales: | Ali, Sulaiman Haji, Aljenaee, K, Wan Mahmood, W A, Hatunic, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744620/ https://www.ncbi.nlm.nih.gov/pubmed/29302330 http://dx.doi.org/10.1530/EDM-17-0110 |
Ejemplares similares
-
Durvalumab-induced diabetic ketoacidosis followed by hypothyroidism
por: Patel, Shivani, et al.
Publicado: (2019) -
A case of pembrolizumab-induced severe DKA and hypothyroidism in a patient with metastatic melanoma
por: Hakami, Osamah A, et al.
Publicado: (2019) -
Autoimmune hypothyroidism and trastuzumab therapy: a rare association
por: Lopes, Valentim, et al.
Publicado: (2023) -
Over-the-counter protein supplement resulting in impaired thyroxine absorption in a hypothyroid patient
por: Kumarathunga, P A D M, et al.
Publicado: (2021) -
Treatment of congenital hypothyroidism in a newborn with malabsorption after subtotal ileum resection
por: Schömig, Charlotte S, et al.
Publicado: (2018)